Table 3

ROC curve analysis for the main comparisons between uADP and AER

Difference between AUCs
ADPAEReGFR
ROCAUCSE95% CIDifferenceP valueDifferenceP valueDifferenceP value
Progression to microalbuminuria
 uADP0.6000.0290.573–0.6260.180<0.0001NTNT
 AER0.7800.0250.757–0.8020.180<0.0001NTNT
 uADP&AER0.7800.0250.757–0.8020.180<0.00014.8 × 10−50.98NTNT
Progression to macroalbuminuria
 uADP0.6270.0440.570–0.6820.218<0.0001NTNT
 AER0.8450.0330.799–0.8840.218<0.0001NTNT
 uADP&AER0.8450.0330.799–0.8840.218<0.00019.2 × 10−50.09NTNT
Progression to ESRD
 uADP0.8420.0290.798–0.8800.0570.040.0100.79
 AER0.7860.0330.736–0.8290.0570.040.0670.14
 eGFR0.8530.0300.809–0.8900.0100.790.0670.14
 uADP&AER0.8420.0290.797–0.8800.0010.900.0570.040.0110.78
 uADP&eGFR0.8820.0230.841–0.9150.0400.140.0960.010.0290.03
  • NT, not tested; uADP&AER, Cox model formed by uADP and AER used together; uADP&eGFR, Cox model formed by uADP and eGFR used together.